About Quarterly Earnings Report Disclosures
| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥39.96B | ¥42.42B | -5.8% |
| Cost of Sales | ¥11.17B | ¥11.41B | -2.1% |
| Gross Profit | ¥28.79B | ¥31.01B | -7.2% |
| SG&A Expenses | ¥25.15B | ¥24.55B | +2.4% |
| Operating Income | ¥3.64B | ¥6.46B | -43.6% |
| Non-operating Income | ¥440M | ¥1.79B | -75.4% |
| Non-operating Expenses | ¥1.43B | ¥301M | +372.8% |
| Ordinary Income | ¥2.66B | ¥7.95B | -66.6% |
| Profit Before Tax | ¥2.65B | ¥7.75B | -65.8% |
| Income Tax Expense | ¥1.01B | ¥1.63B | -38.1% |
| Net Income | ¥1.65B | ¥6.13B | -73.1% |
| Net Income Attributable to Owners | ¥1.74B | ¥6.06B | -71.3% |
| Total Comprehensive Income | ¥3.07B | ¥9.71B | -68.3% |
| Depreciation & Amortization | ¥3.17B | ¥3.39B | -6.6% |
| Interest Expense | ¥240M | ¥232M | +3.4% |
| Basic EPS | ¥39.42 | ¥137.51 | -71.3% |
| Dividend Per Share | ¥23.00 | ¥23.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥70.01B | ¥69.53B | +¥479M |
| Cash and Deposits | ¥22.65B | ¥23.59B | ¥-940M |
| Accounts Receivable | ¥24.92B | ¥26.74B | ¥-1.82B |
| Inventories | ¥11.06B | ¥8.59B | +¥2.47B |
| Non-current Assets | ¥88.73B | ¥89.64B | ¥-914M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥3.39B | ¥8.70B | ¥-5.31B |
| Financing Cash Flow | ¥-3.35B | ¥-5.13B | +¥1.78B |
| Item | Value |
|---|---|
| Net Profit Margin | 4.3% |
| Gross Profit Margin | 72.1% |
| Current Ratio | 131.0% |
| Quick Ratio | 110.3% |
| Debt-to-Equity Ratio | 0.73x |
| Interest Coverage Ratio | 15.16x |
| EBITDA Margin | 17.0% |
| Effective Tax Rate | 38.0% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | -5.8% |
| Operating Income YoY Change | -43.6% |
| Ordinary Income YoY Change | -66.6% |
| Net Income Attributable to Owners YoY Change | -71.3% |
| Total Comprehensive Income YoY Change | -68.3% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 52.12M shares |
| Treasury Stock | 8.04M shares |
| Average Shares Outstanding | 44.08M shares |
| Book Value Per Share | ¥2,082.81 |
| EBITDA | ¥6.81B |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥23.00 |
| Year-End Dividend | ¥24.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| ConsumerHealthCare | ¥48,000 | ¥3.17B |
| EthicalDrug | ¥5M | ¥3.42B |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥90.00B |
| Operating Income Forecast | ¥12.00B |
| Ordinary Income Forecast | ¥12.00B |
| Net Income Attributable to Owners Forecast | ¥9.50B |
| Basic EPS Forecast | ¥215.52 |
| Dividend Per Share Forecast | ¥24.00 |
This data was automatically extracted from XBRL files. Please refer to the original disclosure documents for accuracy.
| Property, Plant & Equipment | ¥26.80B | ¥26.64B | +¥159M |
| Intangible Assets | ¥39.02B | ¥40.36B | ¥-1.34B |
| Goodwill | ¥3.29B | ¥3.62B | ¥-327M |
| Investment Securities | ¥9.32B | ¥8.87B | +¥459M |
| Total Assets | ¥158.74B | ¥159.17B | ¥-435M |
| Current Liabilities | ¥53.42B | ¥54.45B | ¥-1.03B |
| Accounts Payable | ¥5.07B | ¥3.97B | +¥1.10B |
| Short-term Loans | ¥34.33B | ¥34.30B | +¥28M |
| Non-current Liabilities | ¥13.51B | ¥14.93B | ¥-1.42B |
| Long-term Loans | ¥5.52B | ¥6.87B | ¥-1.35B |
| Total Liabilities | ¥66.93B | ¥69.37B | ¥-2.45B |
| Total Equity | ¥91.81B | ¥89.80B | +¥2.01B |
| Capital Stock | ¥6.59B | ¥6.59B | ¥0 |
| Capital Surplus | ¥9.66B | ¥11.69B | ¥-2.02B |
| Retained Earnings | ¥67.89B | ¥67.21B | +¥680M |
| Treasury Stock | ¥-16.25B | ¥-18.27B | +¥2.02B |
| Owners' Equity | ¥91.67B | ¥89.54B | +¥2.13B |
| Working Capital | ¥16.59B | - | - |